<DOC>
	<DOCNO>NCT00103012</DOCNO>
	<brief_summary>This study examine interaction HIV combination medication lopinavir/ritonavir herbal product echinacea , ginseng , ginkgo biloba . Patients HIV infection often take herbal product dietary supplement addition doctor-prescribed medicine treat disease , lessen side effect anti-viral drug , improve overall well . Alternative medicine may , however , interfere elimination lopinavir/ritonavir body , cause either high low blood level drug would expect . This study assess healthy subject potential harm take echinacea , ginseng , ginkgo biloba together lopinavir/ritonavir . Healthy normal volunteer 18 50 year age may eligible study . Candidates screen history , physical examination , blood test , include HIV test pregnancy test woman . Pregnant woman exclude study . Participants come NIH Clinical Center fast overnight follow procedure : Visits 1 2 : A catheter ( plastic tube ) place arm vein collect blood sample . After first sample drawn , subject take 8 mg midazolam syrup two fexofenadine tablet . Midazolam sedative , fexofenadine ( Allegra ) medicine use treat allergy . Subjects give breakfast hour take drug . Blood sample collect 0.5 , 1 , 1.5 , 2 , 2.5 , 3 , 3.5 , 4 , 5 , 6 , 8 24 hour take drug measure blood level fexofenadine . An extra sample collect 4-hour mark measure midazolam level . The catheter remove 8-hour blood draw subject dismiss home . They return follow morning ( visit 2 ) 24-hour blood draw . Visit 3 : From 7 28 day visit 1 , subject begin take lopinavir/ritonavir capsule twice day mouth total 29.5 day . On day 15 return clinic lopinavir/ritonavir blood level do fexofenadine , except sample collect breakfast 0.5 , 1 , 2 , 3 , 4 , 6 , 8 12 hour lopinavir/ritonavir dose . An extra sample collect routine test . The catheter remove 12-hour draw subject dismiss home . The next morning , subject begin take one following : echinacea 500 mg 3 time day ; ginkgo biloba 120 mg twice day ; ginseng 500 mg 3 time day 28 day . Visit 4 : On last day take lopinavir/ritonavir , subject return clinic blood level measurement drug visit 3 , except catheter remove subject dismiss home 8-hour blood draw . Visits 5 6 : On last day take herbal supplement , subject return clinic repeat measurement fexofenadine midazolam level , describe visit 1 2 . At final visit ( visit 6 ) additional blood sample collect repeat laboratory testing .</brief_summary>
	<brief_title>Drug Interactions Echinacea , Ginseng , Ginkgo Biloba Taken With Lopinavir/Ritonavir Healthy Volunteers</brief_title>
	<detailed_description>Patients HIV commonly use herbal product dietary supplement addition medication prescribe physician . Up 73 % patient HIV report use form complementary alternative medicine . As , potential clinically significant drug interaction herbs antiretrovirals become increasingly appreciate . Despite awareness , little known effect commonly use herbal product , echinacea , ginkgo biloba , ginseng , antiretroviral pharmacokinetics . Interacting herbal supplement potential alter protease inhibitor ( PI ) plasma concentration , show St. John 's Wort garlic . Drug interaction may potentially increase antiretroviral concentration , put patient risk toxicity , low drug concentration threshold viral susceptibility , put patient jeopardy antiretroviral failure . The protease inhibitor lopinavir ritonavir rely principally cytochrome P450 ( CYP ) 3A4 metabolism elimination . In addition , drug substrates transport protein p-glycoprotein ( P-gp ) , may also contribute distribution elimination . The primary purpose investigation determine whether herbal supplement Echinacea purpurea , ginkgo biloba , Panax ginseng alter pharmacokinetic property HIV protease inhibitor ( PI ) lopinavir , administer PI combination lopinavir/ritonavir ( LPV/r ) . This open label pharmacokinetic study perform outpatient basis . A total 42 study participant meet inclusion criterion sequentially divide one 3 group , 14 subject receive LPV/r alone combination either E. purpurea , G. biloba , P. ginseng . Subjects begin take LPV/r ( 400mg/100mg twice daily x 29.5 day ) , return NIH Day 15 dose post-dose plasma collection determination lopinavir ritonavir concentration . On Day 16 participant begin take either E. purpurea ( 500mg , three time daily ) , G. biloba extract ( 120 mg , twice daily ) , P. ginseng ( 500 mg , twice daily ) 28 day . On 30th day LPV/r ( Day 15 herb ) , subject return NIH take final LPV/r dose plasma collect determination lopinavir concentration . Data investigation determine whether echinacea , ginseng , ginkgo biloba supplement alter pharmacokinetics lopinavir .</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Males female age 18 50 year . 2 . Healthy medical history physical exam . 3 . Laboratory value within establish guideline participation clinical study : AST le equal 2 time ULN ; SCr le equal ULN ; hemoglobin equal great 11 g/dL ( male female ) . 4 . Ability abstain ingest fruit juice pharmacokinetic sampling period ( total 2 study day ) , abstain eat grapefruit drinking grapefruit juice entire study period . 5 . Negative serum urine pregnancy test female childbearing potential . 6 . Females childbearing potential able willing practice abstinence use nonhormonal effective method birth control study , condom diaphragms . EXCLUSION CRITERIA : 1 . Concomitant routine therapy prescription , overthecounter , herbal , holistic medication , include oral contraceptive , 30 day prior study participation . Intermittent use medication within 30 day prior screen consider case case principal investigator medically accountable investigator . Concomitant therapy ( chronic intermittent ) prescription , overthecounter , herbal drug ( include tincture , food , beverage , gum ) allow study duration , include intermittent use allergy medication . Intermittent use acetaminophen , nonsteroidal antiinflammatory medication ( i.e . ibuprofen ) , loperamide allow study , take day pharmacokinetic blood sampling . A daily multivitamin mineral allow study . 2 . Inability obtain venous access blood sample collection . 3 . The presence history follow : diabetes mellitus ( clinical diagnosis base current guideline , HIV infection , active tuberculosis , cardiac disease ( eg . Hypertension [ SBP great 140 mmHG DBP great 90 mmHG ] , heart failure , arrhythmia , etc . ) , renal disease , hepatitis hepatic impairment , pancreatitis , bleed disorder , internal bleeding ( gastrointestinal intracranial ) , respiratory disease ( eg . asthma require maintenance pharmacologic therapy , chronic obstructive pulmonary disease , etc . ) , peptic ulcer disease , osteoporosis , osteonecrosis , atopy atopic dermatitis , hormone sensitive cancer condition , organ transplant , seizure disorder , schizophrenia psychiatric illness may interfere subject 's ability participate study , condition may interfere interpretation study result best interest subject opinion investigator . 4 . Plans elective surgery investigation within 1 month follow completion subject gingko biloba arm study . 5 . Positive serum urine pregnancy test breastfeed female . 6 . The presence persistent diarrhea malabsorption would interfere subject 's ability absorb drug . 7 . Drug alcohol abuse may impair safety adherence ( 3 alcoholic drink per day , daily basis ) . 8 . History intolerance allergic reaction product contain echinacea , ginkgo biloba extract , ginseng ( include pill , tincture , food , beverage , gum ) . 9 . History intolerance allergic reaction lopinavir , ritonavir , midazolam , fexofenadine . 10 . History atopy include atopic dermatitis , bronchial asthma , multiple food allergy , severe recur allergic rhinitis . 11 . Fasting total cholesterol great 240 mg/dL fast triglyceride great 400 mg/dL . 12 . Use nicotinecontaining tobacco product , include cigarette chew tobacco .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Antiretrovirals</keyword>
	<keyword>Protease Inhibitors</keyword>
	<keyword>Herbal Supplements</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Metabolism</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>